相关实验视频

Updated: Jun 4, 2025

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

一个ER-居民聚合物的抗体介导清除,这种聚合物会导致眼

Minh Thu Ma¹, Ahlam N Qerqez², Kamisha R Hill¹

¹School of Chemistry & Biochemistry, Georgia Institute of Technology, 901 Atlantic Drive NW, Atlanta, GA 30332, USA.

|December 27, 2024

概括

研究人员开发了针对突变肌肉素的抗体,这是与青光眼有关的蛋白质. 这些抗体促进有毒聚合物的降解,为视力丧失和相关的神经退行性疾病提供了潜在的新疗法.

科学领域:

眼科医生眼科眼科
神经科学是一个神经科学.
免疫学免疫学免疫学
细胞生物学细胞生物学

背景情况:

蛋白质错误折叠和聚合与神经退行性疾病有关.
肌素的Olfactomedin (OLF) 域中的突变与青光眼有遗传联系,导致视力丧失.
突变肌肉素聚合在内分泌网膜 (ER),导致ER压力和细胞毒性.

研究的目的:

开发重组抗体,针对肌素的聚合性OLF域.
研究这些抗体在降解致病性肌烯聚合物中的治疗潜力.
探索基于抗体的策略来治疗肌林相关的玻璃眼和其他与蛋白质稳定相关的疾病.

主要方法:

针对myocilin的OLF域的抗体发现活动.
在体外对抗体结合和聚合抑制的表征.
通过自/溶酶体途径评估突变肌素的抗体介导降解.
对ER应激和细胞毒性的抗体影响的评估.

主要成果:

开发了两种复合抗体,即抗OLF1和抗OLF2.
抗OLF2已证明对本地OLF具有选择性,并且在体外抑制了聚合.
这两种抗体都参与了自/溶酶体降解途径,促进了致病性突变肌肉素的清除.
这些抗体显示出有可能破坏ER局部化蛋白质聚合物.

结论:

治疗性抗体可以被设计为向和促进细胞内蛋白质聚合物的降解.
这种方法有望通过精准医学治疗肌素相关的玻璃眼.
增强 lysosomal 降解是一种可行的策略,用于解决玻璃眼和其他疾病中蛋白质稳定性下降的问题.

关键词:

自自是自的过程.分子识别分子识别肌素中的肌素蛋白质的错误折叠蛋白质的错误折叠蛋白质稳定症是一种蛋白质稳定症.

更多相关视频

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

Published on: March 23, 2016

相关概念视频

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Antibody Actions

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...

Cross-reactivity

Cross-reactivity